InvestorsHub Logo
icon url

oilsleuth

02/07/16 7:17 PM

#67281 RE: ca boy #67279

I don't know, maybe because it isn't explicitly worded as being claims to cure them, the idea being for the public to think that the stating of severe medical problems means hemp seed oil will cure them. It's outrageous of course.

How can that get pass the Food and Drug administration compliance enforcement department for false misleading claims?


icon url

scion

02/08/16 8:50 AM

#67329 RE: ca boy #67279

How can that get pass the Food and Drug administration compliance enforcement department for false misleading claims ?

Department of Health and Human Services

Public Health Service
Food and Drug Administration


February 26, 2015

WARNING LETTER


VIA OVERNIGHT DELIVERY
RETURN RECEIPT REQUESTED

Natural Organic Solutions
Attn: Joe Cain
1001 Cooper Point Rd. SW
Ste.140 #149
Olympia, WA 98502

1675 Mottman Rd. SW
Tumwater, WA 98512

Dear Joe Cain:

This is to advise you that the Food and Drug Administration (FDA) has reviewed your web site at the internet address www.purecbd.net and your Etsy.com marketplace store at the internet address www.etsy.com/shop/PureCBD in February 2015, and has determined that you take orders for several products claiming to contain cannabidiol (CBD), such as (but not limited to), “CBD Hemp Oil Treatment,” “Hemp CBD (Cannabidiol) Extract Capsules,” “CBD Extract Capsules Anti Anxiety Formula,” and “High CBD Healing Salve.” FDA also reviewed literature which accompanies the sale and shipment of your products. Based on our review, we have determined that your websites and accompanying literature promote these products for conditions that cause them to be drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(B)] because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. As explained further below, the introduction or delivering these products for introduction into interstate commerce for such uses violates the Act.

[...]
more
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2015/ucm436066.htm